Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | PTGFR | P43088 | 1/20 | 0.30 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 2/20 | 0.30 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9398978 | 0.89 | TSHR (0.34) | TSHRNFKB1CYP2C19LMNA | |
| SCHEMBL716438 | 0.84 | TSHR (0.39) | FFAR4FFAR1ALDH1A1GSTK1TSHR | |
| SCHEMBL716439 | 0.78 | TSHR (0.39) | FFAR4FFAR1ALDH1A1TSHRNFKB1 | |
| SCHEMBL28098157 | 0.77 | FFAR4 (0.47) | FFAR4FFAR1ALDH1A1TSHRNFKB1 | |
| SCHEMBL27403917 | 0.76 | TSHR (0.40) | FFAR4FFAR1ALDH1A1TSHRNFKB1 | |
| SCHEMBL2052956 | 0.75 | FFAR4 (0.39) | FFAR4FFAR1ALDH1A1GSTK1TSHR | |
| SCHEMBL27703377 | 0.71 | ZDHHC7 (0.37) | FFAR1ALDH1A1 | |
| SCHEMBL27460275 | 0.71 | CYP2C19 (0.43) | ALDH1A1TSHRNFKB1CYP2C19LMNA | |
| SCHEMBL194968 | 0.71 | NAAA (0.38) | ALDH1A1TSHRNFKB1CYP2C19LMNA | |
| SCHEMBL27703376 | 0.71 | NAAA (0.38) | ALDH1A1TSHRNFKB1CYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115926668-A | Multilayer co-extrusion type high-reliability white EVA (ethylene-vinyl acetate) adhesive film and preparation method thereof | 常州斯威克光伏新材料有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-109929168-B | Modified polyethylene material suitable for electric power insulator and preparation method thereof | 中蓝晨光化工研究设计院有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-109929169-B | Modified polyethylene material for electric power insulator and preparation method thereof | 中蓝晨光化工研究设计院有限公司 | 2022-03-29 | — | — | CN | claimed |
| CN-114196343-A | High-weather-resistance heat-conducting photovoltaic gap film and preparation method thereof | 常州斯威克光伏新材料有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-114015399-A | High-strength flame-retardant two-component silane modified polyether adhesive and preparation method thereof | 广州市白云化工实业有限公司 | 2022-02-08 | — | — | CN | claimed |
| CN-111425671-B | Three-layer co-extrusion antibacterial PP-R water supply pipe and preparation method thereof | 广东联塑科技实业有限公司 | 2022-01-28 | — | — | CN | claimed |
| CN-113897790-A | Carbon fiber TPU coated manufacturing method and modified TPU carbon fiber yarn thereof | 信泰(福建)科技有限公司 | 2022-01-07 | — | — | CN | claimed |
| CN-112921502-A | Antibacterial and antiviral melt-blown fabric and preparation method thereof | 河南驼人医疗器械研究院有限公司 | 2021-06-08 | — | — | CN | claimed |
| CN-108753184-B | Silane-grafted POE adhesive film for photovoltaic packaging and preparation method thereof | 常州斯威克光伏新材料有限公司 | 2021-02-26 | — | — | CN | claimed |
| CN-111793442-A | Three-layer co-extrusion composite adhesive film for packaging photovoltaic module and preparation method thereof | 常州斯威克光伏新材料有限公司 | 2020-10-20 | — | — | CN | claimed |
| EP-1885787-B1 | PHOSPHITE ADDITIVES IN POLYOLEFINS | PHILLIPS PETROLEUM CO (US) | 2018-01-10 | — | — | EP | claimed |
| US-7157511-B2 | Phosphite additives in polyolefins | CHEVRON PHILLIPSCHEMICAL COMPANY LP | 2007-01-02 | — | — | US | claimed |
| US-20050113494-A1 | Phosphite additives in polyolefins | THE HUNTINGTON NATIONAL BANK | 2005-05-26 | — | — | US | claimed |
| US-20260070275-A1 | FLUOROPOLYMER FREE POLYMER PROCESSING AIDS | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2026-03-12 | — | — | US | disclosed |
| EP-4702064-A1 | POLYMERIZATION PROCESS, HDPE POLYETHYLENE COMPOSITION AND ROTOMOLDED ARTICLE | Nova Chemicals (International) S.A. (CH) | 2026-03-04 | — | — | EP | disclosed |
| EP-4702062-A1 | LINEAR HIGH-DENSITY POLYETHYLENE COMPOSITION AND ROTOMOLDED ARTICLE | Nova Chemicals (International) S.A. (CH) | 2026-03-04 | — | — | EP | disclosed |
| US-3956298-A | POLYMER STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
| US-3943096-A | Use of hydroxyphenylurethanes for stabilising elastomers | CIBA-GEIGY CORPORATION (US) | 1976-03-09 | — | — | US | disclosed |
| US-3943098-A | 1-Aza-4-thiacyclohexane-4,4-dioxide derivatives and their use as agents protecting against light rays | CIBA-GEIGY CORPORATION (US) | 1976-03-09 | — | — | US | disclosed |
| US-3939175-A | STABILIZER | CIBA-GEIGY CORPORATION (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070275-A1 | FLUOROPOLYMER FREE POLYMER PROCESSING AIDS | PFKP, LCP1, PIGK | FFAR4 904/4885FFAR1 720/4885ALDH1A1 4418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.